Does Bladder Cancer Show Up In Blood Tests?

Bladder cancer is a serious condition, and if you’re worried about it, you might wonder if it can be detected with a simple blood test.

The truth is, blood tests aren’t typically used to diagnose bladder cancer directly.

While they can help rule out other issues or check your general health, they don’t confirm whether cancer is present in the bladder.

This guide explains what blood tests can reveal, why urine tests and scans play a bigger role, and what signs to look out for.

Why are blood tests ordered if bladder cancer is suspected?

When a doctor suspects bladder cancer, they might order blood tests alongside other diagnostic tools. However, it’s essential to note that these tests do not directly detect the cancer itself.

Instead, blood tests can:

Check how well your kidneys and liver are working.
Look for signs of infection.
Show whether you’ve lost a lot of blood (if you’ve noticed blood in your urine).
Give an idea of your overall health before further investigations.

For example, a full blood count (FBC) can reveal anaemia, which may suggest long-term blood loss. A urea and electrolytes (U&E) test checks kidney function, especially important if there’s a blockage or tumour pressing on the urinary tract.

None of these results confirm cancer. They simply highlight changes in your body that may support a diagnosis later.

What bladder cancer tests look for

To find bladder cancer, specialists usually focus on the bladder itself, not just the bloodstream. That’s because early-stage cancers tend to stay localised. Here are the main ways it’s investigated:

Urine tests

Urine cytology looks for abnormal cells shed into the urine. While this test can detect cancer cells, it’s not always reliable. Some low-grade tumours don’t shed many cells, so a negative result doesn’t always mean you’re clear.

Other urine-based tests look for markers like NMP22, BTA, or UroVysion. These can support a diagnosis but, again, aren’t foolproof on their own.

Cystoscopy

This is often the go-to test. A thin camera is passed through the urethra to look directly inside the bladder. If anything unusual is spotted, a biopsy can be taken there and then. It’s this sample that confirms whether you’ve got cancer and what type it is.

Imaging

A CT urogram or ultrasound scan may be used to see whether there’s a tumour, how big it is, and whether it’s spread. These scans give more insight into your urinary tract than any blood test can.

Can any blood marker suggest bladder cancer?

There’s no specific blood marker used to detect bladder cancer like there is for prostate (PSA) or ovarian cancer (CA125). However, a few patterns might raise concern:

Low red blood cell count (anaemia) may hint at internal bleeding.
Raised white cell count or CRP might suggest inflammation or infection.
Abnormal kidney results may point to blockage from a tumour.

These changes can happen in many non-cancer conditions. That’s why doctors don’t rely on blood tests alone when bladder cancer is suspected.

Can blood tests help after diagnosis?

Yes. Once bladder cancer is confirmed, blood tests play a bigger role. They help:

Monitor your response to treatment.
Track any side effects of chemotherapy or immunotherapy.
Keep an eye on how your organs are coping during treatment.
Detect signs of spread (for example, liver function tests may highlight metastasis).

Doctors might order regular tests to tailor your care, especially if you’re undergoing surgery, BCG therapy, or systemic treatment.

Why symptoms still matter most

If you’re experiencing any of the following signs, don’t wait for a blood test to tell you something is wrong:

Blood in your urine (even once).
Needing to urinate more often or urgently.
Pain when passing urine.
Lower back pain (around the kidneys).

These symptoms don’t always mean cancer, but they do need checking. Early bladder cancer often causes changes in urination, so it’s important to speak to your GP if you notice anything odd.

Related read: Does Bladder Cancer Cause Pain?

The importance of early referral

Your GP can refer you to a urology specialist under the NHS two-week wait pathway if bladder cancer is suspected. You don’t need a blood test to trigger this referral. Visible blood in the urine should lead to urgent investigation, even if you’re otherwise well.

Delays in referral or waiting for blood test results can hold up diagnosis, so if you’ve got symptoms, it’s best to act fast.

Can blood tests help rule cancer out?

Not really. While a normal blood test result may be reassuring, it doesn’t rule out bladder cancer. A cystoscopy or scan is still needed if there are symptoms or if your urine shows something unusual.

You shouldn’t rely on blood tests to give you the all-clear. Instead, they should be part of a bigger picture, alongside clinical examination and specific bladder-focused tests.

Final notes

While blood tests provide useful health information, they can’t detect the cancer itself. They’re part of the journey, not the destination.

If you’ve noticed changes in your urine or are concerned about bladder cancer, don’t wait for blood results. Speak to your doctor, ask about a referral, and take the next step towards clarity and care.

Further reading: Is Bladder Cancer Curable?

Maneesh Ghei

Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.